Navigation Links
Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear
Date:10/1/2010

M&A land the resolution of Sanofi-Aventis' bid to acquire Genzyme will continue to unfold after its first offer, valued at $18 billion, was rejected. The fall will also be a very busy time for U.S. drug approvals with over 20 marketing applications to be decided before year's end by the regulators at the U.S. Food and Drug Administration," concluded Burrill.

Biotech IPO Activity

"IPO activity across all sectors picked up in the quarter, but in order to attract investors and get deals done, companies had to be willing to trim their price expectations even in the wake of the strengthening equity markets," noted Burrill.

Three biotech companies amended their prices to go public in the third quarter. Antibiotic developer Trius Therapeutics slashed its expected share price by 62 percent to complete its offering selling 10 million shares at $5 per share. The San Diego biotech plans to begin a late stage trial to evaluate torezolid, its lead next-generation antibiotic, against Pfizer's Zyvox linezolid to treat acute bacterial skin and skin structure infections.

Specialty pharmaceutical company NuPathe raised $50 million after trimming its offering price to $10 from its original $14 to $16 range. NuPathe is focused on treatments for diseases of the central nervous system.

Amyris Biotechnologies, which uses genetically modified yeast to make products for the specialty chemical/fuel markets, raised $85 million by offering 5.3 million shares at $16, below the range of $18-$20. However, its post-IPO trading was positive with the company's shares closing the month up 7.8 percent. Amyris plans to continue its growth through alliances with big-cap companies and has focused on using Brazil's vast resources of sugar cane to help create products. The company plans to use proceeds of the IPO for capital spending, working capital and corporate purposes, including the construction of engineering service capabilities to support sugar and etha
'/>"/>

SOURCE Burrill & Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
2. The Number of Biotechnology Companies has Only Decreased by 10% Despite the Crisis
3. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
4. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
5. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
6. Nanobiotechnology experts join forces to improve TB testing
7. Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company
8. PROLOR Biotechs Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society
9. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
10. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
11. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Boston, MA (PRWEB) August 21, 2014 ... collaboration company, has been recognized as one of ... 500 | 5000 magazine for the 2nd consecutive ... on its 33rd annual Inc. 500|5000, an exclusive ... list represents the most comprehensive look at the ...
(Date:8/20/2014)... history lessons often have it that American Indians largely ... chicken pox, influenza and tuberculosis brought to the New ... vary, about 20 million people lived in the Americas ... them were killed by European diseases., But new research ... University and Johannes Krause of the University of Tubingen ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
(Date:8/20/2014)... SAN JOSE, Calif. , Aug. 20, 2014 ... UCSD highlights the transformative collaboration between the school,s ... (IoT).  As part of the Intel® Software Academic ... between computer sciences and the human body.  ... The study exhibits the work of ...
Breaking Biology Technology:SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2
... June 28, 2011 GeneTex, a leading manufacturer of ... that they will be launching a full line of ... as a model organism for scientific research. Due to their ... a useful model for genetic studies. Zebrafish eggs are ...
... While the health benefits of oregano oil is widely known ... from Global Healing Center is one of the most potent ... why it,s gaining popularity as a health supplement. ... 80% Carvacrol, a compound that is known scientifically for its ...
... 27, 2011 Metro Atlanta is building its reputation ... of Emory University and Children,s Healthcare of Atlanta, two ... million pediatric research facility. "Atlanta has a ... to continued medical advances that will benefit patients not ...
Cached Biology Technology:GeneTex Antibody Company to Launch a Line of New Zebrafish Primary Antibodies 2Organic Oregano Oil Gaining Popularity in Natural Health Field, According to Global Healing Center 2MAC Members Grow Atlanta's Bioscience Reputation 2MAC Members Grow Atlanta's Bioscience Reputation 3
(Date:8/20/2014)... John and Rebecca Moores Professor of Biology and Biochemistry at ... the International Society for the Study of the Origin of ... two from the U.S., one from France and one ... elected every three years, and 36 have been named since ... countries, the ISSOL includes researchers from disciplines as varied as ...
(Date:8/20/2014)... SALT LAKE CITY Researchers at Huntsman Cancer Institute (HCI) ... mutated forms of the gene that encodes BCR-ABL, the ... (CML). According to the American Cancer Society, nearly 6,000 ... , Drugs already in use, called tyrosine kinase inhibitors ... disease. They do not cure CML but control it ...
(Date:8/20/2014)... OTTAWA , Aug. 20, 2014 /CNW/ -  ... without warning and can quickly become life threatening for some ... As many as 1.2 million Canadians have food allergies and ... six per cent of children are estimated to have food ... range from mild skin irritations and hives to breathing difficulties ...
Breaking Biology News(10 mins):UH professor named fellow by International Astrobiology Society 2Blueprint for next generation of chronic myeloid leukemia treatment 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... (March 9, 2009)Osteoplastya highly effective minimally invasive ... metastatic bone disease by injecting bone cement ... pain relief, often presenting individuals who are ... effect," according to researchers at the Society ...
... for strokes has taken a significant step forward today ... stroke-damaged brain tissue in rats. The team of ... Research Council (BBSRC) and led by Dr Mike Modo ... The work, carried out at the Institute of Psychiatry ...
... much less expensive means of making artemisinin, the most ... also help to extend the effectiveness of this drug. ... be done at far lower costs than extracting the ... tree, making microbial-based artemisinin a much cheaper but equally ...
Cached Biology News:Metastatic bone disease patients can walk in Lazarus' footsteps 2Metastatic bone disease patients can walk in Lazarus' footsteps 3Stem cells replace stroke-damaged tissue in rats 2Synthetic biology can help extend anti-malaria drug effectiveness 2Synthetic biology can help extend anti-malaria drug effectiveness 3Synthetic biology can help extend anti-malaria drug effectiveness 4
... Clone/PAD: ZMD.471. Immunogen: Synthetic peptide ... the mouse junctophilin-1. Specificity: Specific ... Mouse (positive controls: mouse brain and ... and skeletal muscle tissues). Applications: ...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
HSV 1 IgM...
... Printing Surface (3 glass slides coated with 100 /500/1000 ... wafer coated with 1000 Angstroms of Gold over TI ... (3 PDMS micropatterned stamps with series of 100 / ... or 200 um x 10 mm lines, 3 PDMS ...
Biology Products: